Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day

Paracetamol is widely used as an antipyretic and analgesic. Adverse effects are regarded as unlikely at doses below 150 mg/kg per day. However, lower doses have resulted in hepatotoxicity, and there is growing evidence of the potential for hepatotoxicity in children given multiple therapeutic or sup...

Full description

Saved in:
Bibliographic Details
Published in:Medical journal of Australia Vol. 171; no. 9; p. 497
Main Authors: Hynson, Jenny L, South, Mike
Format: Journal Article
Language:English
Published: Australia 01-11-1999
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Paracetamol is widely used as an antipyretic and analgesic. Adverse effects are regarded as unlikely at doses below 150 mg/kg per day. However, lower doses have resulted in hepatotoxicity, and there is growing evidence of the potential for hepatotoxicity in children given multiple therapeutic or supratherapeutic doses of paracetamol. The nomogram devised by Rumack and Matthews was based on data obtained from previously well adult patients who had taken a single large dose of paracetamol. The relevance of this to children given multiple doses in the context of a febrile illness is unknown, particularly as the metabolism in this population appears to be quite different. It has been suggested that the therapeutic index for paracetamol may be as low as 1.7, and that sick children under the age of two years given in excess of 90 mg/kg per day for more than one day should be regarded as being at higher risk. The product information recommends a maximum daily dose of 60 mg/kg, but it is not uncommon for children to receive doses in excess of 90 mg/kg per day in the hospital setting. Although the number of reported cases of hepatotoxicity induced by therapeutic doses of paracetamol is small, it is possible that cases have gone unrecognised. It is important to administer the drug with caution and according to current dosage guidelines.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0025-729X
1326-5377
DOI:10.5694/j.1326-5377.1999.tb123758.x